Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Adjunctive Pimavanserin in Patients With Major Depressive Disorder and an Inadequate Response to Therapy (CLARITY).

Fava M, Dirks B, Freeman MP, Papakostas GI, Shelton RC, Thase ME, Trivedi MH, Liu K, Stankovic S.

J Clin Psychiatry. 2019 Sep 24;80(6). pii: 19m12928. doi: 10.4088/JCP.19m12928.

2.

The Widely Conserved ebo Cluster Is Involved in Precursor Transport to the Periplasm during Scytonemin Synthesis in Nostoc punctiforme.

Klicki K, Ferreira D, Hamill D, Dirks B, Mitchell N, Garcia-Pichel F.

MBio. 2018 Nov 27;9(6). pii: e02266-18. doi: 10.1128/mBio.02266-18.

3.

Distinguishing the efficacy and sedative effects of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.

Huss M, McBurnett K, Cutler AJ, Hervás A, Bliss C, Gao J, Dirks B, Newcorn JH.

Eur Neuropsychopharmacol. 2019 Mar;29(3):432-443. doi: 10.1016/j.euroneuro.2018.05.012. Epub 2018 Jul 29.

4.

The 10 fundamental principles of lay resuscitation: Recommendations by the German Resuscitation Council.

Böttiger BW, Dirks B, Jost U, Kreimeier U, Osche S, Roessler M, Scholz KH, Wingen S.

Eur J Anaesthesiol. 2018 Oct;35(10):721-723. doi: 10.1097/EJA.0000000000000865. No abstract available.

5.

Long-term safety and efficacy of guanfacine extended release in children and adolescents with ADHD.

Huss M, Dirks B, Gu J, Robertson B, Newcorn JH, Ramos-Quiroga JA.

Eur Child Adolesc Psychiatry. 2018 Oct;27(10):1283-1294. doi: 10.1007/s00787-018-1113-4. Epub 2018 Feb 13.

PMID:
29442229
6.

Prevalence of nosocomial pathogens in German ambulances: the SEKURE study.

Wepler M, Stahl W, von Baum H, Wildermuth S, Dirks B, Georgieff M, Hafner S.

Emerg Med J. 2015 May;32(5):409-11. doi: 10.1136/emermed-2013-202551. Epub 2015 Feb 24.

PMID:
25714107
7.

Safety and pharmacokinetics of lisdexamfetamine dimesylate in adults with clinically stable schizophrenia: a randomized, double-blind, placebo-controlled trial of ascending multiple doses.

Martin P, Dirks B, Gertsik L, Walling D, Stevenson A, Corcoran M, Raychaudhuri A, Ermer J.

J Clin Psychopharmacol. 2014 Dec;34(6):682-9. doi: 10.1097/JCP.0000000000000205.

PMID:
25310201
8.

Development of a modified gentamicin protection assay to investigate the interaction between Campylobacter jejuni and Acanthamoeba castellanii ATCC 30010.

Dirks BP, Quinlan JJ.

Exp Parasitol. 2014 May;140:39-43. doi: 10.1016/j.exppara.2014.03.012. Epub 2014 Mar 13.

PMID:
24632191
9.

Treatment With Lisdexamfetamine Dimesylate Improves Self- and Informant-Rated Executive Function Behaviors and Clinician- and Informant-Rated ADHD Symptoms in Adults: Data From a Randomized, Double-Blind, Placebo-Controlled Study.

Weisler R, Ginsberg L, Dirks B, Deas P, Adeyi B, Adler LA.

J Atten Disord. 2017 Dec;21(14):1198-1207. doi: 10.1177/1087054713518242. Epub 2014 Jan 24.

PMID:
24464328
10.

Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate.

Weisler RH, Adler LA, Kollins SH, Goodman DW, Hamdani M, Dirks B, Childress AC.

Neuropsychiatr Dis Treat. 2014;10:1-12. doi: 10.2147/NDT.S47087. Epub 2013 Dec 9.

11.

Bispectral index (BIS) and suppression ratio (SR) as an early predictor of unfavourable neurological outcome after cardiac arrest.

Selig C, Riegger C, Dirks B, Pawlik M, Seyfried T, Klingler W.

Resuscitation. 2014 Feb;85(2):221-6. doi: 10.1016/j.resuscitation.2013.11.008. Epub 2013 Nov 25.

PMID:
24287327
12.

Novel carbon nanotube-conjugated polymer nanohybrids produced by multiple polymer processing.

Stranks SD, Habisreutinger SN, Dirks B, Nicholas RJ.

Adv Mater. 2013 Aug 21;25(31):4365-71.

PMID:
24137628
14.

Treatment outcomes with lisdexamfetamine dimesylate in children who have attention-deficit/hyperactivity disorder with emotional control impairments.

Katic A, Dirks B, Babcock T, Scheckner B, Adeyi B, Richards C, Findling RL.

J Child Adolesc Psychopharmacol. 2013 Aug;23(6):386-93. doi: 10.1089/cap.2012.0104.

15.

Lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study.

Adler LA, Dirks B, Deas PF, Raychaudhuri A, Dauphin MR, Lasser RA, Weisler RH.

J Clin Psychiatry. 2013 Jul;74(7):694-702. doi: 10.4088/JCP.12m08144.

PMID:
23945447
16.

Adjunctive lisdexamfetamine dimesylate therapy in adult outpatients with predominant negative symptoms of schizophrenia: open-label and randomized-withdrawal phases.

Lasser RA, Dirks B, Nasrallah H, Kirsch C, Gao J, Pucci ML, Knesevich MA, Lindenmayer JP.

Neuropsychopharmacology. 2013 Oct;38(11):2140-9. doi: 10.1038/npp.2013.111. Epub 2013 May 8.

17.

Efficacy and safety of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder and recent methylphenidate use.

Jain R, Babcock T, Burtea T, Dirks B, Adeyi B, Scheckner B, Lasser R, Renna J, Duncan D.

Adv Ther. 2013 May;30(5):472-86. doi: 10.1007/s12325-013-0027-2. Epub 2013 May 17.

18.

Production of high-purity single-chirality carbon nanotube hybrids by selective polymer exchange.

Stranks SD, Baker AM, Alexander-Webber JA, Dirks B, Nicholas RJ.

Small. 2013 Jul 8;9(13):2245-9. doi: 10.1002/smll.201202434. Epub 2013 Feb 22.

PMID:
23436691
19.

Parent-reported executive function behaviors and clinician ratings of attention-deficit/hyperactivity disorder symptoms in children treated with lisdexamfetamine dimesylate.

Findling RL, Adeyi B, Dirks B, Babcock T, Scheckner B, Lasser R, DeLeon A, Ginsberg LD.

J Child Adolesc Psychopharmacol. 2013 Feb;23(1):28-35. doi: 10.1089/cap.2011.0120.

PMID:
23410139
20.

ADHD Symptom Rebound and Emotional Lability With Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years.

López FA, Childress A, Adeyi B, Dirks B, Babcock T, Scheckner B, Lasser RA, Shepski J, Arnold V.

J Atten Disord. 2017 Jan;21(1):52-61. doi: 10.1177/1087054712474685. Epub 2016 Jul 28.

PMID:
23407278
21.

Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.

Mattingly GW, Weisler RH, Young J, Adeyi B, Dirks B, Babcock T, Lasser R, Scheckner B, Goodman DW.

BMC Psychiatry. 2013 Jan 29;13:39. doi: 10.1186/1471-244X-13-39.

22.

Salmonella and Escherichia coli O157:H7 survival in soil and translocation into leeks (Allium porrum) as influenced by an arbuscular mycorrhizal fungus (Glomus intraradices).

Gurtler JB, Douds DD Jr, Dirks BP, Quinlan JJ, Nicholson AM, Phillips JG, Niemira BA.

Appl Environ Microbiol. 2013 Mar;79(6):1813-20. doi: 10.1128/AEM.02855-12. Epub 2013 Jan 11.

24.

Attention deficit hyperactivity disorder subtypes and symptom response in adults treated with lisdexamfetamine dimesylate.

Mattingly G, Weisler R, Dirks B, Babcock T, Adeyi B, Scheckner B, Lasser R.

Innov Clin Neurosci. 2012 May;9(5-6):22-30.

25.

The effects of lisdexamfetamine dimesylate on emotional lability in children 6 to 12 years of age with ADHD in a double-blind placebo-controlled trial.

Childress AC, Arnold V, Adeyi B, Dirks B, Babcock T, Scheckner B, Lasser R, Lopez FA.

J Atten Disord. 2014 Feb;18(2):123-32. doi: 10.1177/1087054712448252. Epub 2012 Jun 26.

PMID:
22740112
26.

Fate of patients with prehospital resuscitation for ST-elevation myocardial infarction and a high rate of early reperfusion therapy (results from the PREMIR [Prehospital Myocardial Infarction Registry]).

Koeth O, Nibbe L, Arntz HR, Dirks B, Ellinger K, Genzwürker H, Tebbe U, Schneider S, Friedrich J, Zahn R, Zeymer U; PREMIR Investigators.

Am J Cardiol. 2012 Jun 15;109(12):1733-7. doi: 10.1016/j.amjcard.2012.02.013. Epub 2012 Mar 31.

PMID:
22465316
27.

Treatment of raw poultry with nonthermal dielectric barrier discharge plasma to reduce Campylobacter jejuni and Salmonella enterica.

Dirks BP, Dobrynin D, Fridman G, Mukhin Y, Fridman A, Quinlan JJ.

J Food Prot. 2012 Jan;75(1):22-8. doi: 10.4315/0362-028X.JFP-11-153.

PMID:
22221351
28.

Sex subgroup analysis of treatment response to lisdexamfetamine dimesylate in children aged 6 to 12 years with attention-deficit/hyperactivity disorder.

McGough JJ, Greenbaum M, Adeyi B, Babcock T, Scheckner B, Dirks B, Findling RL.

J Clin Psychopharmacol. 2012 Feb;32(1):138-40. doi: 10.1097/JCP.0b013e318240dc53. No abstract available.

PMID:
22217951
29.

Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysis.

Jain R, Babcock T, Burtea T, Dirks B, Adeyi B, Scheckner B, Lasser R.

Child Adolesc Psychiatry Ment Health. 2011 Nov 4;5(1):35. doi: 10.1186/1753-2000-5-35.

30.

Clinical utility of ADHD symptom thresholds to assess normalization of executive function with lisdexamfetamine dimesylate treatment in adults.

Brown TE, Brams M, Gasior M, Adeyi B, Babcock T, Dirks B, Scheckner B, Wigal T.

Curr Med Res Opin. 2011;27 Suppl 2:23-33. doi: 10.1185/03007995.2011.605441.

PMID:
21973229
31.

Long-term treatment outcomes with lisdexamfetamine dimesylate for adults with attention-deficit/hyperactivity disorder stratified by baseline severity.

Ginsberg L, Katic A, Adeyi B, Dirks B, Babcock T, Lasser R, Scheckner B, Adler LA.

Curr Med Res Opin. 2011 Jun;27(6):1097-107. doi: 10.1185/03007995.2011.567256. Epub 2011 Mar 28.

PMID:
21438796
32.

Detection and enumeration of Dekkera anomala in beer, cola, and cider using real-time PCR.

Gray SR, Rawsthorne H, Dirks B, Phister TG.

Lett Appl Microbiol. 2011 Apr;52(4):352-9. doi: 10.1111/j.1472-765X.2011.03008.x. Epub 2011 Feb 7.

33.

Executive function deficits in children with attention-deficit/hyperactivity disorder and improvement with lisdexamfetamine dimesylate in an open-label study.

Turgay A, Ginsberg L, Sarkis E, Jain R, Adeyi B, Gao J, Dirks B, Babcock T, Scheckner B, Richards C, Lasser R, Findling RL.

J Child Adolesc Psychopharmacol. 2010 Dec;20(6):503-11. doi: 10.1089/cap.2009.0110.

34.

Clinically relevant changes in emotional expression in children with ADHD treated with lisdexamfetamine dimesylate.

Katic A, Ginsberg L, Jain R, Adeyi B, Dirks B, Babcock T, Scheckner B, Richards C, Lasser R, Turgay A, Findling RL.

J Atten Disord. 2012 Jul;16(5):384-97. doi: 10.1177/1087054710389990. Epub 2010 Dec 20.

PMID:
21173426
35.

[Comments on the 2010 guidelines on cardiopulmonary resuscitation of the European Resuscitation Council].

Wenzel V, Russo SG, Arntz HR, Bahr J, Baubin MA, Böttiger BW, Dirks B, Kreimeier U, Fries M, Eich C.

Anaesthesist. 2010 Dec;59(12):1105-23. doi: 10.1007/s00101-010-1820-9. German.

PMID:
21125214
36.

The quality of emergency medical care in baden-württemberg (Germany): four years in focus.

Messelken M, Kehrberger E, Dirks B, Fischer M.

Dtsch Arztebl Int. 2010 Jul;107(30):523-30. doi: 10.3238/arztebl.2010.0523. Epub 2010 Jul 30. Review.

37.

Images in resuscitation: ECG misinterpretion underneath high-voltage power lines.

Hoppe K, Dirks B, Stahl W, Muth CM, Klingler W.

Resuscitation. 2009 Sep;80(9):973-4. doi: 10.1016/j.resuscitation.2009.06.006. Epub 2009 Jul 5. No abstract available.

PMID:
19581041
38.

Randomized, double-blind, placebo-controlled study of paliperidone extended-release and quetiapine in inpatients with recently exacerbated schizophrenia.

Canuso CM, Dirks B, Carothers J, Kosik-Gonzalez C, Bossie CA, Zhu Y, Damaraju CV, Kalali AH, Mahmoud R.

Am J Psychiatry. 2009 Jun;166(6):691-701. doi: 10.1176/appi.ajp.2009.08040613. Epub 2009 May 1.

PMID:
19411369
39.

Direct and indirect effects of paliperidone extended-release tablets on negative symptoms of schizophrenia.

Turkoz I, Bossie CA, Dirks B, Canuso CM.

Neuropsychiatr Dis Treat. 2008 Oct;4(5):949-58.

40.

Reperfusion rate and inhospital mortality of patients with ST segment elevation myocardial infarction diagnosed already in the prehospital phase: results of the German Prehospital Myocardial Infarction Registry (PREMIR).

Zeymer U, Arntz HR, Dirks B, Ellinger K, Genzwürker H, Nibbe L, Tebbe U, Senges J, Schneider S; PREMIR-Investigators.

Resuscitation. 2009 Apr;80(4):402-6. doi: 10.1016/j.resuscitation.2008.12.004. Epub 2009 Jan 22.

PMID:
19167147
41.

[Chest compression without ventilation during basic life support? Confirmation of the validity of the European Resuscitation Council (ERC) guidelines 2005].

Kreimeier U, Dirks B, Arntz R, Bahr J, Goldschmidt P, Roessler M, Sasse M, Toursarkissian M.

Anaesthesist. 2008 Aug;57(8):812-6. doi: 10.1007/s00101-008-1384-0. German.

PMID:
18493728
42.

Sea anemone genome reveals ancestral eumetazoan gene repertoire and genomic organization.

Putnam NH, Srivastava M, Hellsten U, Dirks B, Chapman J, Salamov A, Terry A, Shapiro H, Lindquist E, Kapitonov VV, Jurka J, Genikhovich G, Grigoriev IV, Lucas SM, Steele RE, Finnerty JR, Technau U, Martindale MQ, Rokhsar DS.

Science. 2007 Jul 6;317(5834):86-94.

43.

The genome of black cottonwood, Populus trichocarpa (Torr. & Gray).

Tuskan GA, Difazio S, Jansson S, Bohlmann J, Grigoriev I, Hellsten U, Putnam N, Ralph S, Rombauts S, Salamov A, Schein J, Sterck L, Aerts A, Bhalerao RR, Bhalerao RP, Blaudez D, Boerjan W, Brun A, Brunner A, Busov V, Campbell M, Carlson J, Chalot M, Chapman J, Chen GL, Cooper D, Coutinho PM, Couturier J, Covert S, Cronk Q, Cunningham R, Davis J, Degroeve S, Déjardin A, Depamphilis C, Detter J, Dirks B, Dubchak I, Duplessis S, Ehlting J, Ellis B, Gendler K, Goodstein D, Gribskov M, Grimwood J, Groover A, Gunter L, Hamberger B, Heinze B, Helariutta Y, Henrissat B, Holligan D, Holt R, Huang W, Islam-Faridi N, Jones S, Jones-Rhoades M, Jorgensen R, Joshi C, Kangasjärvi J, Karlsson J, Kelleher C, Kirkpatrick R, Kirst M, Kohler A, Kalluri U, Larimer F, Leebens-Mack J, Leplé JC, Locascio P, Lou Y, Lucas S, Martin F, Montanini B, Napoli C, Nelson DR, Nelson C, Nieminen K, Nilsson O, Pereda V, Peter G, Philippe R, Pilate G, Poliakov A, Razumovskaya J, Richardson P, Rinaldi C, Ritland K, Rouzé P, Ryaboy D, Schmutz J, Schrader J, Segerman B, Shin H, Siddiqui A, Sterky F, Terry A, Tsai CJ, Uberbacher E, Unneberg P, Vahala J, Wall K, Wessler S, Yang G, Yin T, Douglas C, Marra M, Sandberg G, Van de Peer Y, Rokhsar D.

Science. 2006 Sep 15;313(5793):1596-604.

44.

[The new 2005 resuscitation guidelines of the European Resuscitation Council: comments and supplements].

Wenzel V, Russo S, Arntz HR, Bahr J, Baubin MA, Böttiger BW, Dirks B, Dörges V, Eich C, Fischer M, Wolcke B, Schwab S, Voelckel WG, Gervais HW; European Resuscitation Council.

Anaesthesist. 2006 Sep;55(9):958-66, 968-72, 974-9. Review. German.

PMID:
16915404
45.

The right to informed consent or the right to life.

Dirks B.

Resuscitation. 2002 Jun;53(3):241. No abstract available.

PMID:
12062835
46.

[DIVI emergency medicine protocol, version 4.0].

Moecke H, Dirks B, Friedrich HJ, Hennes HJ, Lackner CK, Messelken M, Neumann C, Pajonk FG, Reng M, Schächinger U, Violka T.

Anaesthesist. 2000 Mar;49(3):211-3. German. No abstract available.

PMID:
10788991
47.

Repetition of parasuicide--ICD-10 personality disorders and adversity.

Dirks BL.

Acta Psychiatr Scand. 1998 Sep;98(3):208-13.

PMID:
9761407
48.
49.

Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation.

Lindner KH, Dirks B, Strohmenger HU, Prengel AW, Lindner IM, Lurie KG.

Lancet. 1997 Feb 22;349(9051):535-7.

PMID:
9048792
50.

Active compression-decompression cardiopulmonary resuscitation--instructor and student manual for teaching and training. Part II: A student and instructor manual.

Wik L, Schneider T, Baubin M, Dirks B, Ellinger K, Gisch T, Haghfelt T, Plaisance P, Vandemheen K.

Resuscitation. 1996 Oct;32(3):206-12. No abstract available.

PMID:
8923583

Supplemental Content

Support Center